BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026.
World J Transplant. Jun 18, 2026; 16(2): 118012
Published online Jun 18, 2026. doi: 10.5500/wjt.v16.i2.118012
Table 3 Coronavirus disease 2019 vaccines (adult)-recommended use and clinical notes in chronic liver disease/Liver transplantation
Vaccine (brand)
Recommended adult use
Clinical notes in CLD/LT
Pfizer–BioNTech (Comirnaty®; mRNA)Updated/seasonal dose(s) per national guidance for adultsPreferred platform for most CLD/LT due to strong effectiveness and safety experience. Responses may be attenuated and additional boosters often needed
Moderna (Spikevax®; mRNA)
AstraZeneca (Vaxzevria®; viral vector)Where available/used: 2-dose primary series per local policy; boosters typically with an updated vaccineGenerally not first-line for immunocompromised patients. Heterologous boosting with mRNA may improve breadth of responses


Write to the Help Desk